James E. Flynn 13D and 13G filings for Nuo Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 09:01 am Sale | 2024-09-30 | 13G | Nuo Therapeutics, Inc. AURX | James E. Flynn | 1,026,324 2.200% | -1,156,840 (-52.99%) | Filing |
| 2024-02-12 5:33 pm Sale | 2023-12-31 | 13G | Nuo Therapeutics, Inc. AURX | James E. Flynn | 2,183,164 5.160% | -516,836 (-19.14%) | Filing |
| 2020-10-09 3:29 pm Purchase | 2020-10-05 | 13G | Nuo Therapeutics, Inc. AURX | James E. Flynn | 2,700,000 9.240% | 2,700,000 (New Position) | Filing |